The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Prof. Dr. Paul Brinkkoetter
500 participants
Apr 1, 2018
OBSERVATIONAL
Conditions
Summary
In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.
Eligibility
Inclusion Criteria6
- written informed consent
- or less years of age
- idiopathic nephrotic syndrome
- written informed consent
- older or equal to 18 years of age
- biopsy-proven primary or secondary FSGS or MCD or biopsy-proven recurrence of disease in kidney transplant.
Exclusion Criteria4
- Prior kidney transplant without biopsy-proven recurrence
- A clinical diagnosis of other glomerular disease resulting in secondary MCD or FSGS as judged by the treating physicians.
- Refusal to provide written informed consent
- (Anticipated) incompliance with visit schedule
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biosampling at initial visit and follow-up visits
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03949972